The nation of Zimbabwe has turned down a substantial American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years because of Washington's demand for sensitive data.
The decision became public after a official document from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".
An official representative later explained that the US was seeking biological samples for scientific study and commercial gain but was unwilling to guarantee the resulting advantages from future treatments.
"We are forced to start the difficult and regrettable task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged more negotiations to reach a deal suitable to both sides so the country's vital HIV treatment initiative can be sustained.
Wider Background
Zimbabwe's decision follows a similar case in neighbouring Kenya, where a court halted a similar deal with the US after concerns were raised about the safety of citizens' medical information.
Since returning to the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had managed assistance for the US government, but Trump stated its spending was "inefficient" and his government was pursuing government-to-government agreements to boost transparency and accountability.
According to statements, Sixteen nations in Africa have so far agreed to similar health pacts, representing over $18.3bn of fresh investment.
Details of the Declined Deal
The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment through US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, with no equivalent guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," he stated.
"Put simply, our country would supply the basic resources for scientific discovery with no certainty that the final treatments would be available to our people should a new pandemic arise."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting systems already established via the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.
"This mechanism is intended to ensure that when a country contributes its information, the benefits – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to create them."
These objections regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome further dialogue with our US partners on how subsequent co-operation could be structured in a way that honours the sovereignty and interests of each country."
Medical Community Response
Medical experts stated it understood the government's concerns, but suggested that talks should continue since a large portion of the nation's HIV programmes depended on external financing.
"Where technical issues exist, including those involving data governance or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," it added.
The halted deal emphasises the ongoing tensions between accepting much-needed foreign assistance and protecting local interests in an ever more data-driven world.